keyboard_arrow_up

Market Research Review on Osteoarthritis - Epidemiology Forecast to 2024

​EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024 is a new market research publication announced by Reportstack. OA is a degenerative disease of the entire joint, which involves the cartilage, joint lining, ligaments, and underlying bone. OA is the most common form of joint disease. The most affected joints are the knee, hip, hand, and spine. The disease’s onset is gradual and typically seen in middle-aged to elderly people. OA is characterized by pain, stiffness, swelling, crepitus, and limited movement of the affected joint. OA will be the fourth leading cause of disability by the year 2020.

The epidemiologists forecast an increase in the total prevalent cases of hand OA in the 7MM from 150,635,612 total prevalent cases in 2014 to 175,213,683 total prevalent cases in 2024 at an AGR of 1.63% during the forecast period. The epidemiologists forecast that the total prevalent cases of knee OA in the 7MM are expected to increase from 110,840,501 total prevalent cases in 2014 to 127,929,359 total prevalent cases in 2024 at an AGR of 1.54% during the forecast period. The epidemiologists forecast that the total prevalent cases of hip OA in the 7MM are expected to increase from 61,150,916 total prevalent cases in 2014 to 69,699,696 total prevalent cases in 2024 at an AGR of 1.4% during the forecast period. The diagnosed prevalent cases of hand OA in the 7MM are expected to increase from 61,045,590 diagnosed prevalent cases in 2014 to 70,996,375 diagnosed prevalent cases in 2024 at an AGR of 1.63% during the forecast period. The diagnosed prevalent cases of knee OA in the 7MM are expected to increase from 37,845,305 diagnosed prevalent cases in 2014 to 43,877,213 diagnosed prevalent cases in 2024 at an AGR of 1.59% during the forecast period. The diagnosed prevalent cases of hip OA in the 7MM are expected to increase from 15,116,094 diagnosed prevalent cases in 2014 to 17,276,030 diagnosed prevalent cases in 2024 at an AGR of 1.43% during the forecast period.

To access full report with TOC, please visit​ EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2024.

Scope

- The ​Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for hand OA, knee OA, and hip OA in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). The report also includes a 10-year epidemiological forecast for the total prevalent cases and diagnosed prevalent cases of hand OA, knee OA, and hip OA segmented by age and gender in these markets.
- The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast series will allow you to - 
- Develop business strategies by understanding the trends shaping and driving the global OA market.
- Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and Gender that present the best opportunities for OA therapeutics in each of the markets covered.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

​Reportstack Market Research

###